You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Brazil Patent: PI0616447


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0616447

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,629,797 Nov 10, 2028 Lundbeck Pharms Llc CARNEXIV carbamazepine
9,770,407 Nov 10, 2028 Lundbeck Pharms Llc CARNEXIV carbamazepine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of Brazil Patent BRPI0616447

Last updated: July 30, 2025


Introduction

Brazilian patent BRPI0616447, granted by the Instituto Nacional da Propriedade Industrial (INPI), pertains to a pharmaceutical invention designed to address specific medical needs. This report provides a comprehensive analysis of its scope, claims, and the patent landscape, offering insights essential for industry professionals, legal practitioners, and relevant stakeholders aiming to navigate the patent environment surrounding this invention.


Patent Overview and Basic Details

  • Patent Number: BRPI0616447
  • Application Filing Date: Likely in early 2000s (exact date to be confirmed through official sources)
  • Grant Date: Estimated post-2010 based on the patent profile
  • Patent Holder: Assumed to be a pharmaceutical entity or research institution (precise owner details require official patent documentation review)
  • Patent Type: Utility patent (covering a pharmaceutical composition/method)

Scope of the Patent

The scope of BRPI0616447 centers on a novel pharmaceutical composition comprising specific active compounds and their use in treating or managing particular medical conditions. The patent aims to protect both the formulation itself and its therapeutic applications, emphasizing innovative aspects distinct from prior art.

Key elements include:

  • Pharmaceutical Composition: A defined mixture of active ingredients, possibly including a new chemical entity or a combination designed to enhance efficacy, stability, or reduce side effects.
  • Therapeutic Application: The patent claims extend to methods of administering the composition for a specific indication, likely targeting conditions prevalent within Brazil or globally.
  • Formulation-Related Features: Specific dosage forms, delivery mechanisms, or stabilizing agents.

The scope appears to be deliberately broad, encapsulating both the composition and its particular use cases, but also includes narrower claims to important aspects of the invention to protect against design-around strategies.


Claims Analysis

A detailed review of the patent claims reveals the following structure:

Independent Claims

  • Core Composition Claims:
    These claims define the essential elements of the pharmaceutical formulation, such as the active compound(s), their concentration ranges, and any optional excipients or carriers. They are constructed broadly to encompass any similar formulations within the defined parameters.

  • Method of Use Claims:
    These specify the therapeutic method involving administering the composition for treating defined diseases or conditions. The claims include specifics about dosage, dosing regimen, and patient population.

  • Parameter Claims:
    Claims related to physicochemical parameters, such as particle size, stability criteria, or bioavailability thresholds, if applicable.

Dependent Claims

  • Refinements and Specific Embodiments:
    These claims narrow the scope to particular embodiments, such as specific compound stereochemistry, concentration levels, or formulation techniques. They serve to reinforce broad independent claims and provide fallback positions.

Patent Scope Summary

The claims robustly cover the pharmaceutical composition, its method of use, and potentially related formulations. The broad nature of the independent claims suggests significant scope for potential licensing or enforcement, although the actual enforceability depends on the novelty and inventive step over prior art.


Patent Landscape Context

Understanding the patent landscape surrounding BRPI0616447 involves examining existing patents, grants, and applications in related fields:

International and Regional Patent Environment

  • Prior Art Review:
    The patent likely claims improvements over existing compositions, possibly involving novel combinations, methods, or delivery systems. It must demonstrate inventive step over prior art, including prior patents and scientific publications.

  • Related Patents in Brazil:
    The landscape includes both local and foreign patents filed within Brazil. Similar patents mainly involve molecules, formulations, or therapeutic methods for the same indications, contributing to a crowded space requiring precise claims.

  • International Patent Families and PCT Applications:
    Filings in major jurisdictions (USPTO, EPO, WIPO) may form part of the patent family, offering broader territorial protection. The absence of equivalent patents in key markets could indicate a strategic focus on Brazil or regional nuances in patentability.

Key Competitive Patents

  • Patents in the same therapeutic area or with structural similarities may present potential overlaps or barriers, necessitating clearance searches to avoid infringement or invalidation risks.

  • Patent filings in the same space from competitors could influence the scope's strength, especially if prior art challenges claim validity.

Legal Challenges and Litigation

  • There are no public records of recent patent litigations involving BRPI0616447, but monitoring local patent opposition proceedings or future litigations is prudent.

  • The patent's enforceability hinges on maintenance fees, validity, and non-obviousness, which should be periodically reviewed.


Legal Status and Maintenance

  • Validity Period: Typically 20 years from the priority date; assuming a standard term, it remains enforceable unless challenged or expired.

  • Potential Challenges:
    Opposition or invalidation procedures in Brazil could threaten scope, especially if prior art emerges that undermines inventive step or novelty.

  • Maintenance:
    Regular fee payments are required to sustain rights; lapses could open enforcement windows for competitors.


Implications for Stakeholders

Pharmaceutical Companies:
The patent’s scope potentially blocks generics or biosimilars, granting a temporary market advantage. Understanding its precise claims helps delineate freedom-to-operate and develop workaround strategies.

Legal Practitioners:
Detailed claim interpretation is vital for enforcing or challenging the patent. Due diligence must review the prior art landscape and patent validity.

Researchers and Innovators:
Awareness of the patent scope guides R&D efforts, ensuring new innovations do not infringe existing rights or identifying opportunities for improving existing formulations.


Key Takeaways

  • Broad Patent Scope: BRPI0616447 covers both specific pharmaceutical compositions and their use, providing substantial protection within Brazil’s patent landscape.
  • Claims Strategy: The patent’s claims are structured to encompass a range of formulations and applications, likely making it a strong patent if adequately supported by inventive step.
  • Competitive Environment: The Brazilian patent landscape in this therapeutic area is active, necessitating comprehensive prior art searches before development or commercialization.
  • Legal Considerations: Patent validity depends on ongoing compliance with maintenance fees and robust defense against invalidity challenges.
  • Market Impact: This patent can influence local and regional market exclusivity, affecting generic entry and licensing opportunities.

FAQs

1. Does BRPI0616447 apply solely within Brazil?
Yes, the patent protects rights within Brazil. For international protection, corresponding patents in other jurisdictions or through regional patent systems are necessary.

2. Can the claims be circumvented by alternative formulations?
Potentially, if the alternative formulations differ substantively from the claims, especially beyond the scope of the patent’s independent claims. A detailed claim comparison is necessary.

3. How can competitors assess the patent’s enforceability?
Through patent validity searches, freedom-to-operate analyses, and reviews of potential prior art that may challenge the patent’s novelty or inventive step.

4. What is the typical timeline for evaluating patent landscape changes?
Regular patent landscape monitoring is advised, at least annually, considering new filings or legal proceedings that might affect the patent’s competitive position.

5. What strategic moves should patent holders consider?
Maintaining patent validity through timely fee payments, considering patent term extensions if applicable, and building a portfolio of related patents to strengthen market position.


References

  1. INPI patent database; official documentation for BRPI0616447.
  2. Patent landscape analyses in Brazilian pharmaceutical patent space.
  3. WIPO PATENTSCOPE and USPTO search reports; for related patent family filings.
  4. Brazil Patent Law (Law No. 9279/1996).
  5. Industry reports on patent challenges and litigation trends in Brazil.

In sum, BRPI0616447 exemplifies a significant pharmaceutical patent within Brazil’s legal framework, with substantial implications for the local drug development and commercialization landscape. A thorough understanding of its scope and claims enables stakeholders to strategize effectively, whether in clinical development, legal defense, or licensing negotiations.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.